Governor Glenn Youngkin Announces AstraZeneca Selects Virginia for Multi-Billion Dollar Manufacturing Center

RICHMOND, VA — Governor Glenn Youngkin announced AstraZeneca, a global biopharmaceutical company focused on the research, development, and commercialization of prescription medicines, selected Virginia for its largest single facility investment ever as part of their plan to invest $50 billion in the United States by 2030. At the announcement, Governor Youngkin was joined by AstraZeneca CEO Pascal Soriot and company leadership, as well as White House National Economic Council Director Kevin Hassett.